Clinical Trials Browser

Niclosamide × Genitourinary × 90 days × Clear all

NCT03123978 2026-05-06

Enzalutamide and Niclosamide in Treating Patients With Recurrent or Metastatic Castration-Resistant Prostate Cancer

Phase 1 Completed

Prostatic Neoplasms